Association between type II secretory phospholipase Asub2/sub plasma concentrations and activity and cardiovascular events in patients with coronary heart disease

Ähnliche Einträge

• Type II secretory phospholipase A2 and prognosis in patients with stable coronary heart disease: Mendelian randomization study
  Veröffentlicht: (2011)
• Genotype and plasma concentration of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events
  Veröffentlicht: (2005)
• Secretory phospholipase A2-IIA and cardiovascular disease: a mendelian randomization study
  Veröffentlicht: (2013)
• Increased plasma concentrations of soluble ST2 independently predict mortality but not cardiovascular events in stable coronary heart disease patients: 13-year follow-up of the KAROLA study
  von: Pfetsch, Vanessa, et al.
  Veröffentlicht: (2017)
• Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: More than simply a marker of glomerular filtration rate
  Veröffentlicht: (2005)